Sanofi Ventures

Sanofi Ventures is the corporate venture capital arm of Sanofi, focusing on early-stage biotech and digital health companies that align with Sanofi's strategic areas of interest. Founded in 2001 and headquartered in Cambridge, Massachusetts, the fund actively invests in fields like immunology, oncology, rare diseases, cell and gene therapy, and digital health. With over 105 investments, the firm partners with companies that are developing breakthrough therapies and technologies aimed at transforming healthcare. Sanofi Ventures plays a hands-on role in its portfolio, often leading rounds from seed to Series B and beyond. What sets it apart from traditional VCs is the added access to Sanofi's deep expertise in clinical development, regulatory pathways, and commercialization strategies. This allows its portfolio companies to scale efficiently and navigate complex healthcare markets. Notable portfolio companies include Nura Bio (focused on neuroprotective therapies), Carbon Health (a modern healthcare provider), and Granite Bio (targeting autoimmune and inflammatory diseases). Sanofi Ventures also seeks to foster long-term partnerships, aiming to accelerate growth while preparing companies for potential acquisition or further financing opportunities​.